According to the first study, conducted in Brazil, researchers found four vaccines provide additional protection against symptomatic reinfe...

The firm, which counts Medikabazaar, Ekincare, Healthifyme and Qure.ai in its portfolio of invested companies, has got global pharma maker ...

Arundhati Bhattacharya, Chief Executive Officer and Chairperson, Salesforce India who has assumed the role of IAC Chair said the council pl...

The fund has received commitments from global financial and strategic institutions, including some global pharma and health-tech companies,...

“We have submitted an application to the Drugs Controller General of India (DCGI) requesting approval to conduct a bridging clinical study ...

Scientists and drug companies across the world are accelerating various treatments and vaccine options to tackle Covid-19, which has claime...

India's dependency on charity from global drug makers is making it hard for patients to access new antibiotic drugs such as bedaquiline and...

There is no doubt that India is still a highly attractive and viable option for low-cost labour, albeit not quite as good as it was 15 year...

The transaction, which is expected to close this week, marks the Ajay Piramal-led company’s sixth deal in the healthcare space in the past ...

A ‘miracle drug’ to battle multi-drug resistant tuberculosis MDR-TB, and extensively-drug resistant TB (XDR-TB), will be rolled out on Mond...

Dishman Pharmaceuticals and Chemicals today said it has received a licence from Johnson & Johnson to manufacture raw material for a tubercu...

Dishman Pharmaceuticals and Chemicals surged 16.22 per cent to close at 306.95. The stock closed at a fresh 52-week high on Wednesday.

Taken orally once a day, Invokana belongs to a new class of medications which work in a completely different way to other classes of type 2...

Jubilant Biosys will carry out research services and deliver preclinical candidates to Janssen for potential development and commercialisat...

After gaining market access under a USFDA contingency plan, Sun Pharma is awaiting approval for its cancer drug Lipodox.

"India offers several advantages in R&D, but it's behind," said Bart Janssens, a BCG partner and coauthor of the report.

As the offshore services market matures, transformation and process improvement are likely to play a growing role in companies business pro...